1. Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer
- Author
-
F. Van den Heuvel, F. Fiorini, S. Teoh, Katherine A. Vallis, and Ben George
- Subjects
Organs at Risk ,Relative risk reduction ,Lung Neoplasms ,Heart disease ,VMAT ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,Left coronary artery ,medicine.artery ,Relative biological effectiveness ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Radiation treatment planning ,Lung cancer ,Proton therapy ,business.industry ,Patient Selection ,Radiotherapy Planning, Computer-Assisted ,Radiotherapy Dosage ,Hematology ,Cardiac toxicity ,medicine.disease ,Cardiotoxicity ,Oncology ,030220 oncology & carcinogenesis ,Original Article ,Radiotherapy, Intensity-Modulated ,Protons ,Complication ,business ,Nuclear medicine - Abstract
Highlights • Dose to the heart and all its substructures were significantly lower with IMPT compared to VMAT. • Our analysis showed that not all patients benefit equally from proton beam therapy. • Patients with disease involvement overlapping with or are inferior to the most superior aspect of the heart contour appear to have the highest benefit. The median level of the superior aspect of the heart contour began was T7 vertebra., Purpose/objective To use a model-based approach to identify a sub-group of patients with locally advanced lung cancer who would benefit from proton therapy compared to photon therapy for reduction of cardiac toxicity. Material/methods Volumetric modulated arc photon therapy (VMAT) and robust-optimised intensity modulated proton therapy (IMPT) plans were generated for twenty patients with locally advanced lung cancer to give a dose of 70 Gy (relative biological effectiveness (RBE)) in 35 fractions. Cases were selected to represent a range of anatomical locations of disease. Contouring, treatment planning and organs-at-risk constraints followed RTOG-1308 protocol. Whole heart and ub-structure doses were compared. Risk estimates of grade⩾3 cardiac toxicity were calculated based on normal tissue complication probability (NTCP) models which incorporated dose metrics and patients baseline risk-factors (pre-existing heart disease (HD)). Results There was no statistically significant difference in target coverage between VMAT and IMPT. IMPT delivered lower doses to the heart and cardiac substructures (mean, heart V5 and V30, P
- Published
- 2020
- Full Text
- View/download PDF